TEAS RF New Application

EMGALITY

Eli Lilly and Company

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)

Trademark/Service Mark Application, Principal Register

Serial Number: 87263356
Filing Date: 12/09/2016

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 87263356
MARK INFORMATION
*MARK EMGALITY
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT EMGALITY
MARK STATEMENT The mark consists of standard characters, without claim to any particular font, style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Eli Lilly and Company
*STREET Lilly Corporate Center
*CITY Indianapolis
*STATE
(Required for U.S. applicants)
Indiana
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. applicants)
46285
PHONE 317 651 1346
FAX 317 276 1919
EMAIL ADDRESS XXXX
WEBSITE ADDRESS www.lilly.com
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Indiana
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT The mark is a coined, non-dictionary word with no English translation.
ATTORNEY INFORMATION
NAME Bruce W. Longbottom
FIRM NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
COUNTRY United States
ZIP/POSTAL CODE 46285
PHONE 317 651 1346
FAX 317 276 1919
EMAIL ADDRESS trademarks@lilly.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY John Rudolph, Douglas K. Norman, Lawrence T. Welch
CORRESPONDENCE INFORMATION
NAME Bruce W. Longbottom
FIRM NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
COUNTRY United States
ZIP/POSTAL CODE 46285
PHONE 317 651 1346
FAX 317 276 1919
*EMAIL ADDRESS trademarks@lilly.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
FEE PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /blongbottom/
SIGNATORY'S NAME Bruce W. Longbottom
SIGNATORY'S POSITION Assistant General Counsel
SIGNATORY'S PHONE NUMBER 317 651 1346
DATE SIGNED 12/09/2016



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)


Trademark/Service Mark Application, Principal Register

Serial Number: 87263356
Filing Date: 12/09/2016

To the Commissioner for Trademarks:

MARK: EMGALITY (Standard Characters, see mark)
The literal element of the mark consists of EMGALITY.
The mark consists of standard characters, without claim to any particular font, style, size, or color.

The applicant, Eli Lilly and Company, a corporation of Indiana, having an address of
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
      317 651 1346(phone)
      317 276 1919(fax)
      XXXX (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Miscellaneous Statement
The mark is a coined, non-dictionary word with no English translation.

For informational purposes only, applicant's website address is: www.lilly.com

The applicant's current Attorney Information:
      Bruce W. Longbottom and John Rudolph, Douglas K. Norman, Lawrence T. Welch of Eli Lilly and Company      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
      317 651 1346(phone)
      317 276 1919(fax)
      trademarks@lilly.com (authorized)


The applicant's current Correspondence Information:
      Bruce W. Longbottom
      Eli Lilly and Company
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      317 651 1346(phone)
      317 276 1919(fax)
      trademarks@lilly.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or applicant's attorney at the e-mail address provided above. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in an additional processing fee of $50 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

The signatory believes that: if the applicant is filing the application under 15 U.S.C. § 1051(a), the applicant is the owner of the trademark/service mark sought to be registered; the applicant is using the mark in commerce on or in connection with the goods/services in the application; the specimen(s) shows the mark as used on or in connection with the goods/services in the application; and/or if the applicant filed an application under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e), the applicant is entitled to use the mark in commerce; the applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the goods/services in the application. The signatory believes that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive. The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /blongbottom/   Date: 12/09/2016
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Assistant General Counsel
RAM Sale Number: 87263356
RAM Accounting Date: 12/09/2016

Serial Number: 87263356
Internet Transmission Date: Fri Dec 09 12:20:01 EST 2016
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-201612091220019
33043-87263356-5708d944365a86659cd961778
c8bbb466a4bc47e94621fb5ba1464b6797a36194
-DA-9374-20161209120906456745

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed